Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SI | P14410 | 1/20 | 0.32 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8606220 | 0.95 | LMNA (0.34) | TSHRLMNAPOLBALDH1A1CYP4F2 | |
| Dimethyl Succinate SCHEMBL300065 | 0.85 | TSHR (0.41) | TSHRLMNAALDH1A1KMT2AEPHX2 | |
| Alcohol SCHEMBL20676748 | 0.81 | KMT2A (0.35) | KMT2AL3MBTL1GAACYP2D6 | |
| SCHEMBL39066 | 0.80 | KMT2A (0.33) | KMT2AL3MBTL1GAACYP2D6 | |
| SCHEMBL11391378 | 0.80 | ALDH1A1 (0.41) | TSHRLMNAPOLBALDH1A1KMT2A | |
| SCHEMBL27499875 | 0.80 | TSHR (0.38) | TSHREPHX2 | |
| Succinic Acid SCHEMBL2719778 | 0.80 | APEX1 (0.31) | LMNA | |
| SCHEMBL23074471 | 0.78 | EPHX2 (0.33) | KMT2AEPHX2CYP2D6 | |
| Dimethyl Succinate SCHEMBL28072491 | 0.78 | KDM4E (0.32) | TSHRLMNA | |
| Succinic Acid Diethyl Ester SCHEMBL9323519 | 0.78 | TSHR (0.38) | TSHRLMNAPOLBALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 659 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023199980-A1 | RESIN COMPOSITION, RESIN ADDITIVE COMPOSITION, RESIN STRUCTURE, METHOD FOR IMPROVING WEATHER RESISTANCE, METHOD FOR PRODUCING RESIN COMPOSITION, AND HINDERED AMINE PHOTOSTABILIZER | 株式会社ADEKA | 2023-10-19 | — | — | WO | claimed |
| EP-4397690-A1 | POLYESTER-BASED PLASTICIZER, VINYL CHLORIDE-BASED RESIN COMPOSITION CONTAINING SAME, AND MOLDED ARTICLE THEREOF | ADEKA CORPORATION (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-12024622-B2 | Composition, thermoplastic resin composition using same, and molded article thereof | ADEKA CORPORATION (JP) | 2024-07-02 | — | — | US | disclosed |
| WO-2024122297-A1 | FLAME-RETARDANT COMPOSITION, FLAME-RETARDANT RESIN COMPOSITION AND MOLDED ARTICLE | 株式会社ADEKA | 2024-06-13 | — | — | WO | disclosed |
| US-20240141094-A1 | CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ADHESIVE | ADEKA CORPORATION (JP) | 2024-05-02 | — | — | US | disclosed |
| EP-4357405-A1 | NUCLEATING AGENT COMPOSITION, RESIN COMPOSITION, MOLDED ARTICLE THEREOF, AND METHOD FOR MANUFACTURING RESIN COMPOSITION | ADEKA CORPORATION (JP) | 2024-04-24 | — | — | EP | disclosed |
| US-11958958-B2 | Method for handling a sample of a biochemical substance with a biochemical tool | ZEON CORPORATION (JP) | 2024-04-16 | — | — | US | disclosed |
| EP-4350057-A1 | THERMOPLASTIC RESIN COMPOSITION, METHOD FOR PRODUCING SHAPED BODY, SHAPED BODY AND USE OF RESIN MATERIAL | ADEKA CORPORATION (JP) | 2024-04-10 | — | — | EP | disclosed |
| EP-3604482-B1 | FLAME RETARDANT COMPOSITION AND FLAME-RETARDANT SYNTHETIC RESIN COMPOSITION CONTAINING SAME | ADEKA CORP (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-20240084065-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | ADEKA CORPORATION (JP) | 2024-03-14 | — | — | US | disclosed |
| US-6069206-A | COMPATIBILITY AGENT COMPRISING SPECIFIED COPOLYMER OF AROMATIC VINYL MONOMER AND POLYMERIZABLE MONOMER | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 2000-05-30 | — | — | US | disclosed |
| US-5900446-A | CONTAINING A COMPATIBILITY AGENT; ADDITION-CONDENSATION COPOLYMER | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-05-04 | — | — | US | disclosed |
| EP-0870793-A2 | Thermally reversible crosslinked matter and its use | NIPPON SHOKUBAI CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| EP-0622404-B1 | Crystalline synthetic resin composition containing a group III or IV metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KK (JP) | 1998-07-08 | — | — | EP | disclosed |
| EP-0767215-A1 | AROMATIC POLYCARBONATE-STYRENE POLYMER RESIN COMPOSITION | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1997-04-09 | — | — | EP | disclosed |
| EP-0622404-A1 | Crystalline synthetic resin composition containing a group III or IV metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1994-11-02 | — | — | EP | disclosed |
| US-5342868-A | Containing alkali metal salt and polyvalent metal salt of a cyclic organophosphoric ester | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1994-08-30 | — | — | US | disclosed |
| US-5112891-A | Cyclic Phosphite Heat Stabilizer | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1992-05-12 | — | — | US | disclosed |
| EP-0483400-A1 | Stabilized chlorinated resin composition | ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1992-05-06 | — | — | EP | disclosed |
| US-5077328-A | Heat resistance in presence of filler | ASAHI DENKA KOGYO K.K. (JP) | 1991-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240084065-A1 | NOVEL COMPOUND, AND CURABLE RESIN COMPOSITION CONTAINING SAID COMPOUND | PSMC6, CAND1, RBX1 | TSHR 4283/4885LMNA 2973/4885POLB 2909/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.